Tuesday, January 31, 2012
Friday, January 27, 2012
Thursday, January 26, 2012
Friday, January 20, 2012
Thursday, January 19, 2012
- clear cell
- mixed epithelial
- yolk sac tumor
- granulosa cell
Wednesday, January 18, 2012
Hello Gynecologic Cancer Survivors and Supporters Group,
Thank you so much for being part of this group. As you may have heard Cancer Hope Network’s social network, HopeNet, will be shutting down Feb 1st 2012.
This service was begun as a trial to increase awareness and knowledge of Cancer Hope Network's core service: one-on-one matching with another cancer survivor. Analysis of the site’s usage and quantity of membership indicate it is not achieving results consistent with what we hope to achieve in our mission and vision. Therefore, the decision has been made to discontinue this aspect of Cancer Hope Network's web services. Please note, the web site is still completely active – only the HopeNet tab will be deactivated.
If you would like to stay in touch with Cancer Hope Network, please join them on Facebook or follow themon Twitter. Also, if at any point you would like to be able to speak one-on-one with a fellow cancer survivor, please contact Cancer Hope Network by email at or phone at 877-HOPNET (877-467-3638) and they can try to match you with one of their support volunteers.
It has been a pleasure getting to know so many of you. You may contact me through my Blog, Women of Teal( womenofteal.blogspot.com).If you are interested in online groups you may want to join Inspire (www.inspire.com) or the ovarian cancer mailing list at ACOR (http://www.acor.org/) . I have been a member of both these groups for five years now and found them very helpful.
May the New Year bring you good health and happiness.
Wishing you all the best,
Every Day is a blessing!
Monday, January 16, 2012
Friday, January 13, 2012
Here is a summary of the popular Chemotherapy treatments, drugs and biologics, used in the treatment of Ovarian Cancer. More complete information can be found at http://www.cancer.gov/drugdictionary
Paclitaxel ( Taxol) & Abraxane
“binds to and stabilizes microtubules,preventing their depolymerization and so inhibiting cellular motility, mitosis and replication”
Remember high school biology and the steps of cell reproduction. This drug affects that process. Abraxane is similar to Paclitaxel but does not use a solvent which causes side effects so it permits the administration of larger doses.
“binds to GC-rich sites in DNA , thereby inducing intrastrand and interstrand DNA cross-link, as well as DNA-protein cross- links...results in apoptosis and cell growth inhibition.”
This platinum drug binds to the Guanine and Cytosine rungs on the DNA helix and causes cell growth to stop and then cell death occurs.
Gemcitabine ( Gemzar)
“is converted intracellularly to the active metabolites dFdCPD and dFdCTP... thereby decreasing the deoxynucleotide pool available for DNA synthesis and ... is incorporated into DNA , resulting in DNA strand termination and apoptosis.”
Inside the cell the drug is incorporated in its modified form into the DNA strands and leads to cell death.
“topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery.”
Breaks in the strands of DNA caused by the topotecan prevents the DNA from replicating correctly and cell reproduction is inhibited.
“etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.”
Etoposide causes breaks in the DNA thereby affecting cell reproduction and leads to cell death.
Bevacizumab ( Avastin)
“Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels.”
Cancer cells create blood vessels. Bevacizumab is a monoclonal antibody that binds to the vascular endothelial growth factor which helps create and maintain those cancer cell's blood vessels.
Thursday, January 12, 2012
Monday, January 9, 2012
- Estimated new cases of cancer of the ovary in 2012: 22,280
- Estimated deaths - cancer of the ovary : 15,500
- Estimated deaths - cancer of the ovary in New Jersey: 490
- Cancer of the Ovary is the 5th leading cause of death in women .
- In 2008 deaths caused by cancer of the ovary for all ages of woomen: 14,362
- For women 40-59 years of age cancer of the ovary ranked 4th (2008) behind breast,lung and colorectal
- In women 60-79 years of age cancer of the ovary was the 5th (2008) leading cause of death
- 5 Year relative survival rate ( 2001-2007) for ovarian cancer:
- Data shows that 43% of women diagnosed with ovarian cancer were distant , while 16% were regional and 14% were localized.
Sunday, January 8, 2012
Please join us for a very special 5 Course Dinner and Wine pairing at the
Jersey Girl Cafe
John Kafarski, of the Wine Culture Project, will be providing wines specially paired with our dinner menu. John will provide details about the evening's wine pairings, their background, and why they were selected.
Our St. Valentine's Menu:
- First Course: Pan Roasted Baby Lamb Chops - Parsley, Sage, Rosemary, Thyme
- Salad Course: Baby Arugula - Hearts of Palm, Blood Orange, Goat Cheese Custard, Honey Drizzle
- Third Course: Papardelle Pasta - Roasted Beets, Wilted Radicchio, Riccotta Salata, Toasted Almonds
- Chef's Amuse: TBD
- Entree: Seared Swai fish - Shaved Asparagus and Fennel
- Dessert: 3 Tastes of Chocolate Decadence
Proceeds from our dinner will be donated to the Elixir Fund to benefit cancer patients and their caregivers.
Friday, January 6, 2012
On January 17th Rosa's Ristorante and Pizzeria in Hamilton, NJ will host an event to benefit the Teal Tea Foundation. Stop in any time between 11:00 AM and 10:00 PM and mention the Teal Tea Foundation and a portion of the sales will benefit the Foundation. Support doesn't get much easier than that.
Wednesday, January 4, 2012
"This bill establishes an ovarian cancer public awareness campaign in the Department of Health and Senior Services.
Under the provisions of the bill, the Commissioner of Health and Senior Services is required to establish the public awareness campaign to inform the general public about the clinical significance of ovarian cancer and its public health implications. The campaign would include risk factors, symptoms, the need for early detection and methods of treatment.
To carry out the public awareness campaign, the commissioner would, at a minimum:
-- provide for the development of printed educational materials and public service announcements in English and Spanish; and
-- disseminate information for distribution to the public, through a variety of entities, including, but not limited to, local health agencies and clinics, physicians, health care facilities, county offices on aging, pharmacies, libraries, senior citizen centers, other community-based outreach programs and organizations and the department's official website."
Monday, January 2, 2012
|"The length of time during and after treatment in which a patient is living with a disease that does not get worse. Progression-free survival may be used in a clinical study or trial to help find out how well a new treatment works."|